Douglas M. Bennion

724 total citations
21 papers, 546 citations indexed

About

Douglas M. Bennion is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Douglas M. Bennion has authored 21 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 4 papers in Genetics. Recurrent topics in Douglas M. Bennion's work include Renin-Angiotensin System Studies (8 papers), Receptor Mechanisms and Signaling (6 papers) and S100 Proteins and Annexins (4 papers). Douglas M. Bennion is often cited by papers focused on Renin-Angiotensin System Studies (8 papers), Receptor Mechanisms and Signaling (6 papers) and S100 Proteins and Annexins (4 papers). Douglas M. Bennion collaborates with scholars based in United States, Denmark and Netherlands. Douglas M. Bennion's co-authors include Colin Sumners, Robert W. Regenhardt, U. Muscha Steckelings, David J. Pioquinto, Mark Brantly, Daniel L. Purich, Martin Wegman, Jinze Xu, Christiaan Leeuwenburgh and Xiaomin Lu and has published in prestigious journals such as PLoS ONE, Stroke and Hypertension.

In The Last Decade

Douglas M. Bennion

21 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas M. Bennion United States 13 204 162 114 94 94 21 546
Ladonya Jackson United States 10 141 0.7× 227 1.4× 79 0.7× 112 1.2× 54 0.6× 13 659
Quntao Yu China 14 354 1.7× 250 1.5× 71 0.6× 80 0.9× 57 0.6× 24 695
Leonardo Sandrini Italy 16 167 0.8× 161 1.0× 97 0.9× 113 1.2× 20 0.2× 26 595
Mitsuru Sanada Japan 12 74 0.4× 182 1.1× 326 2.9× 202 2.1× 103 1.1× 42 849
Yingmin Li China 14 53 0.3× 273 1.7× 62 0.5× 127 1.4× 28 0.3× 55 703
Carmen M. Labandeira Spain 14 56 0.3× 135 0.8× 75 0.7× 131 1.4× 45 0.5× 22 591
Nobuo Sugo Japan 12 47 0.2× 106 0.7× 67 0.6× 61 0.6× 81 0.9× 54 696
Demetrios Vassilopoulos Greece 14 104 0.5× 163 1.0× 95 0.8× 91 1.0× 20 0.2× 23 658
Anja Flamez Belgium 9 88 0.4× 95 0.6× 30 0.3× 164 1.7× 87 0.9× 21 570
Julia Shanks New Zealand 15 326 1.6× 190 1.2× 68 0.6× 113 1.2× 40 0.4× 28 624

Countries citing papers authored by Douglas M. Bennion

Since Specialization
Citations

This map shows the geographic impact of Douglas M. Bennion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas M. Bennion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas M. Bennion more than expected).

Fields of papers citing papers by Douglas M. Bennion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas M. Bennion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas M. Bennion. The network helps show where Douglas M. Bennion may publish in the future.

Co-authorship network of co-authors of Douglas M. Bennion

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas M. Bennion. A scholar is included among the top collaborators of Douglas M. Bennion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas M. Bennion. Douglas M. Bennion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bennion, Douglas M., et al.. (2024). Photografted Zwitterionic Hydrogel Coating Durability for Reduced Foreign Body Response to Cochlear Implants. ACS Applied Bio Materials. 7(5). 3124–3135. 4 indexed citations
2.
Kocharyan, Arminé, Douglas M. Bennion, Rachel A. Scheperle, et al.. (2024). Combining Intraoperative Electrocochleography with Robotics-Assisted Electrode Array Insertion. Otology & Neurotology. 45(2). 143–149. 7 indexed citations
3.
4.
Bennion, Douglas M., et al.. (2023). Quality Improvement of Pediatric Airway Emergency Carts: Standardization, Streamlining, and Simulation. Cureus. 15(5). e39727–e39727. 2 indexed citations
5.
Al‐Qurayshi, Zaid, Douglas M. Bennion, Jeremy D.W. Greenlee, & Scott M. Graham. (2022). Endoscopic pituitary surgery: National database review. Head & Neck. 44(12). 2678–2685. 6 indexed citations
6.
Gutierrez, Wade R., et al.. (2020). Vascular pedicled flaps for skull base defect reconstruction. Laryngoscope Investigative Otolaryngology. 5(6). 1029–1038. 17 indexed citations
7.
8.
Bennion, Douglas M., Oliver Domenig, Michael F. Waters, et al.. (2018). Protective effects of the angiotensin II AT2 receptor agonist compound 21 in ischemic stroke: a nose-to-brain delivery approach. Clinical Science. 132(5). 581–593. 20 indexed citations
9.
Bennion, Douglas M., Vermalí Rodríguez, Rubén D. Sinisterra, et al.. (2018). Neuroprotection by post‐stroke administration of an oral formulation of angiotensin‐(1–7) in ischaemic stroke. Experimental Physiology. 103(6). 916–923. 28 indexed citations
10.
Bennion, Douglas M., U. Muscha Steckelings, & Colin Sumners. (2018). Neuroprotection via AT2 receptor agonists in ischemic stroke. Clinical Science. 132(10). 1055–1067. 29 indexed citations
11.
Bennion, Douglas M., Kelly M. DeMars, U. Muscha Steckelings, et al.. (2017). Post-stroke angiotensin II type 2 receptor activation provides long-term neuroprotection in aged rats. PLoS ONE. 12(7). e0180738–e0180738. 18 indexed citations
12.
Bennion, Douglas M., et al.. (2016). Serum activity of angiotensin converting enzyme 2 is decreased in patients with acute ischemic stroke. Journal of the Renin-Angiotensin-Aldosterone System. 17(3). 16 indexed citations
13.
Sumners, Colin, et al.. (2016). OS 32-03 ANGIOTENSIN II TYPE 2 RECEPTOR AGONIST EXERTS SUSTAINED NEUROPROTECTIVE EFFECTS IN AGED RATS. Journal of Hypertension. 34(Supplement 1). e390–e390. 1 indexed citations
14.
Bennion, Douglas M., et al.. (2015). Neuroprotective Mechanisms of the ACE2–Angiotensin-(1-7)–Mas Axis in Stroke. Current Hypertension Reports. 17(2). 3–3. 79 indexed citations
15.
Bennion, Douglas M., et al.. (2015). Activation of the Neuroprotective Angiotensin-Converting Enzyme 2 in Rat Ischemic Stroke. Hypertension. 66(1). 141–148. 54 indexed citations
16.
Wegman, Martin, Michael H. Guo, Douglas M. Bennion, et al.. (2014). Practicality of Intermittent Fasting in Humans and its Effect on Oxidative Stress and Genes Related to Aging and Metabolism. Rejuvenation Research. 18(2). 162–172. 97 indexed citations
17.
Joseph, Jason, Adam P. Mecca, Robert W. Regenhardt, et al.. (2014). The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke. Neuropharmacology. 81. 134–141. 55 indexed citations
18.
19.
Regenhardt, Robert W., Douglas M. Bennion, & Colin Sumners. (2013). Cerebroprotective action of angiotensin peptides in stroke. Clinical Science. 126(3). 195–205. 46 indexed citations
20.
Bennion, Douglas M., et al.. (2011). Transient receptor potential vanilloid 1 agonists modulate hippocampal CA1 LTP via the GABAergic system. Neuropharmacology. 61(4). 730–738. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ladonya Jackson Breakdown of academic impact, for papers by Quntao Yu Breakdown of academic impact, for papers by Leonardo Sandrini Breakdown of academic impact, for papers by Mitsuru Sanada Breakdown of academic impact, for papers by Yingmin Li Breakdown of academic impact, for papers by Carmen M. Labandeira Breakdown of academic impact, for papers by Nobuo Sugo Breakdown of academic impact, for papers by Demetrios Vassilopoulos Breakdown of academic impact, for papers by Anja Flamez Breakdown of academic impact, for papers by Julia Shanks
Rankless by CCL
2026